Go Pro
NASDAQ:STAA

STAAR Surgical (STAA) Stock Price, News & Analysis

STAAR Surgical logo
$23.58 +0.47 (+2.03%)
Closing price 09/3/2026 04:00 PM Eastern
Extended Trading
$23.58 0.00 (-0.02%)
As of 05:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About STAAR Surgical Stock (NASDAQ:STAA)

Advanced

Key Stats

Today's Range
$22.71
$23.68
50-Day Range
$22.11
$29.33
52-Week Range
$15.59
$35.87
Volume
798,351 shs
Average Volume
844,300 shs
Market Capitalization
$1.18 billion
P/E Ratio
336.91
Dividend Yield
N/A
Price Target
$28.40
Consensus Rating
Reduce

Company Overview

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAAR Surgical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
72nd Percentile Overall Score

STAA MarketRank™: 

STAAR Surgical scored higher than 72% of companies evaluated by MarketBeat, and ranked 168th out of 913 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    STAAR Surgical has received a consensus rating of Reduce. The company's average rating score is 1.92, and is based on no strong buy ratings, 2 buy ratings, 8 hold ratings, and 3 sell ratings.

  • Upside Potential

    STAAR Surgical has a consensus price target of $28.40, representing about 20.4% upside from its current price of $23.58.

  • Amount of Analyst Coverage

    STAAR Surgical has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about STAAR Surgical's stock forecast and price target.
  • Earnings Growth

    Earnings for STAAR Surgical are expected to grow by 38.46% in the coming year, from $0.39 to $0.54 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of STAAR Surgical is 336.91, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.27.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of STAAR Surgical is 336.91, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.30.

  • Price to Book Value per Share Ratio

    STAAR Surgical has a P/B Ratio of 3.23. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about STAAR Surgical's valuation and earnings.
  • Percentage of Shares Shorted

    14.57% of the float of STAAR Surgical has been sold short.
  • Short Interest Ratio / Days to Cover

    STAAR Surgical has a short interest ratio ("days to cover") of 4.04.
  • Change versus previous month

    Short interest in STAAR Surgical has recently decreased by 11.76%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    STAAR Surgical does not currently pay a dividend.

  • Dividend Growth

    STAAR Surgical does not have a long track record of dividend growth.

  • News Sentiment

    STAAR Surgical has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for STAAR Surgical this week, compared to 6 articles on an average week.
  • Search Interest

    5 people have searched for STAA on MarketBeat in the last 30 days. This is an increase of 25% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, STAAR Surgical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    39.90% of the stock of STAAR Surgical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    96.70% of the stock of STAAR Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about STAAR Surgical's insider trading history.
Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

STAA Stock News Headlines

STAAR Surgical Appoints Ben Park as Chief Technology Officer
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the largest mineral reserve in the country - enough gold for a new Fort Knox, enough copper to rebuild the U.S. electric grid 25 times over. The Trump administration has previously staked positions in MP Materials, Lithium America, Trilogy Metals, and USA Rare Earth - each time shares moved higher. A landmark policy decision expected before November 3 could reprice this stock from $2 to $20 or more within a year.tc pixel
See More Headlines

STAA Stock Analysis - Frequently Asked Questions

STAAR Surgical's stock was trading at $23.09 at the beginning of 2026. Since then, STAA stock has increased by 2.1% and is now trading at $23.58.

STAAR Surgical Company (NASDAQ:STAA) released its earnings results on Wednesday, August, 12th. The medical instruments supplier reported $0.39 earnings per share for the quarter, topping analysts' consensus estimates of $0.22 by $0.17. The company's revenue was up 111.1% compared to the same quarter last year.
Read the conference call transcript
.

STAAR Surgical's board initiated a stock buyback program on Friday, May 16th 2025, which permits the company to repurchase $30,000,000 in shares, according to EventVestor. This means that the company could buy up to 3.2% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board believes its shares are undervalued.

The following companies are subsidiaries of STAAR Surgical: Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.

STAAR Surgical's top institutional shareholders include California State Teachers Retirement System (1.93%), American Capital Management Inc. (1.70%), Defender Capital LLC. (0.87%) and Bank of New York Mellon Corp (0.46%). Insiders that own company stock include Broadwood Partners, LP, Aimee S Weisner, Arthur C Butcher and Elizabeth Yeu Lin.
View institutional ownership trends
.

Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that STAAR Surgical investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Palo Alto Networks (PANW) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
8/12/2026
Today
9/04/2026
Next Earnings (Estimated)
11/04/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:STAA
CIK
718937
Employees
1,211
Year Founded
1982

Price Target and Rating

High Price Target
$37.00
Low Price Target
$13.00
Potential Upside/Downside
+20.4%
Consensus Rating
Reduce
Rating Score (0-4)
1.92
Research Coverage
13 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.07
Trailing P/E Ratio
336.91
Forward P/E Ratio
60.46
P/E Growth
N/A
Net Income
-$80.45 million
Net Margins
1.13%
Pretax Margin
5.12%
Return on Equity
9.05%
Return on Assets
6.99%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.66
Quick Ratio
4.03

Sales & Book Value

Annual Sales
$239.44 million
Price / Sales
4.94
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.29 per share
Price / Book
3.23

Miscellaneous

Outstanding Shares
50,140,000
Free Float
30,137,000
Market Cap
$1.18 billion
Optionable
Optionable
Beta
1.21

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:STAA) was last updated on 9/4/2026 by MarketBeat.com Staff.
From Our Partners